Ultrashort Peptide Bioconjugates are Exclusively Antifungal Agents and Synergize with Cyclodextrin and Amphotericin B

作者: Christopher J. Arnusch , Hannah Ulm , Michaele Josten , Yana Shadkchan , Nir Osherov

DOI: 10.1128/AAC.00468-11

关键词:

摘要: Many natural broad-spectrum cationic antimicrobial peptides (AMPs) possess a general mode of action that is dependent on lipophilicity and charge. Modulating the AMPs by addition fatty acid has been an effective strategy to increase lytic activity can further broaden spectrum AMPs. However, lipophilic modifications narrow exclusively direct fungi are less common. Here, we show short peptide sequences be targeted with structured biomolecules, such as vitamin E cholesterol. The conjugates were active against Aspergillus fumigatus, Cryptococcus neoformans, Candida albicans but not bacteria observed cause membrane perturbation transmission electron microscopy in permeability studies. for C. albicans, selected compounds without cell membrane, synergism was seen conjugate amphotericin B. Moreover, combination β-cyclodextrin, antibacterial emerged compounds. Biocompatibility tested vitro vivo using toxicity assays erythrocytes, macrophages, mice. In cytotoxicity experiments led selective ratios (50% lethal concentration/MIC) up 64 highly antifungal compounds, no murine seen. Taken together, these results highlight importance conjugated structure suggest modulation other biologically relevant hydrophobic moieties, cholesterol E, generate unique bioactivity.

参考文章(42)
Emilie A. Porter, Xifang Wang, Hee-Seung Lee, Bernard Weisblum, Samuel H. Gellman, Non-haemolytic β-amino-acid oligomers Nature. ,vol. 404, pp. 565- 565 ,(2000) , 10.1038/35007145
R L White, D S Burgess, M Manduru, J A Bosso, Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. Antimicrobial Agents and Chemotherapy. ,vol. 40, pp. 1914- 1918 ,(1996) , 10.1128/AAC.40.8.1914
Nicholas Gerard Byrne, David Geraint Owen, High throughput screen ,(1999)
J.J. Torrado, R. Espada, M.P. Ballesteros, S. Torrado-Santiago, Amphotericin B Formulations and Drug Targeting Journal of Pharmaceutical Sciences. ,vol. 97, pp. 2405- 2425 ,(2008) , 10.1002/JPS.21179
K.V.R. Reddy, R.D. Yedery, C. Aranha, Antimicrobial peptides: premises and promises International Journal of Antimicrobial Agents. ,vol. 24, pp. 536- 547 ,(2004) , 10.1016/J.IJANTIMICAG.2004.09.005
Alessandro Tossi, Luca Sandri, Anna Giangaspero, Amphipathic, α‐helical antimicrobial peptides Biopolymers. ,vol. 55, pp. 4- 30 ,(2000) , 10.1002/1097-0282(2000)55:1<4::AID-BIP30>3.0.CO;2-M
Robert E W Hancock, Hans-Georg Sahl, Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nature Biotechnology. ,vol. 24, pp. 1551- 1557 ,(2006) , 10.1038/NBT1267
Yoon-Kyung Park, Kyung-Soo Hahm, Antimicrobial peptides (AMPs): peptide structure and mode of action. Journal of Biochemistry and Molecular Biology. ,vol. 38, pp. 507- 516 ,(2005) , 10.5483/BMBREP.2005.38.5.507
Alexander F. Chu-Kung, Rose Nguyen, Kristen N. Bozzelli, Matthew Tirrell, Chain length dependence of antimicrobial peptide-fatty acid conjugate activity. Journal of Colloid and Interface Science. ,vol. 345, pp. 160- 167 ,(2010) , 10.1016/J.JCIS.2009.11.057